GSK and Adolor – unwanted
Pain, vomiting, accumulated gas, abdominal distention, bloated, delayed flatus, impaired GI motility, delayed defecation, nausea…
Postoperative ileus can fill your patients with unwanted symptoms.
-Postoperative ileus (POI) cannot be reliably predicted before bowel resection surgery
-POI can be a cause for prolonged hospitalization and for increased readmission rates
Is there more you can do to manage your patients’ POI?

Brand name: n/a
Generic name/category: disease awareness
Company: GlaxoSmithKline and Adolor
Country/Market: USA, North America
Indication(s)/use: GI impairment and discomfort
Target: Healthcare Professionals (HCP)
Tagline: n/a
Medium: Print ad
Size/duration: Single-page
Publication/Aired: Surgery News – December 2009
Click here for the full-sized ad and details in the gallery
This ad and thousands more can be seen on the AdPharm gallery, the largest keyword searchable online pharmaceutical advertising gallery.




